Life sciences tools and diagnostics developer QuantuMDx has invested in the Asynt professional range of non-ducted laboratory filtration and fume benchtop cabinets.
The company purchased the cabinets to aid the development of their portable diagnostic device Q-POC, which will provide sample-to-result diagnostic and drug susceptibility testing for a range of diseases in under 20 minutes. The device is due for commercialisation in 2018.
Asynt non-ducted filtration and fume cabinets employ extra-large capacity activated carbon filters for removal of fumes and/or HEPA filters for particulate removal. The filters are up to 30% bigger than that of some other systems and significantly deeper to make fume removal more efficient and effective - and therefore safer.
Fully compliant with COSHH regulations, cabinet airflow is constantly monitored - triggering audible and visual alarms if it falls below optimum levels. All Asynt non-ducted fume cabinets come with a 5 year warranty.
Dr Sam Bhatt, Senior Scientist at QuantuMDx Group Limited, said: "Having reviewed the market for what was available, the Asynt professional range of non-ducted laboratory filtration and fume cabinets were a clear choice because of their excellent
filtration performance, operational safety features, build quality and reliability.
"The technology being established by QuantuMDx is paramount to the improvement of healthcare systems in clinics and hospitals in low middle income countries. The possibility of medics carrying out rapid disease diagnostics in minutes, in the field, leads to an exciting future in DNA analysis utilising miniaturised portable devices.”
